CD47 is a ubiquitously expressed transmembrane glycoprotein that regulates inflammatory responses and tissue repair. Here, we show that normal mice treated with anti-CD47 antibodies, and Cd47-null mice have impaired intestinal mucosal wound healing. Furthermore, intestinal epithelial cell (IEC)-specific loss of CD47 does not induce spontaneous immunemediated intestinal barrier disruption but results in defective mucosal repair after biopsyinduced colonic wounding or Dextran Sulfate Sodium (DSS)-induced mucosal damage. In vitro analyses using primary cultures of CD47-deficient murine colonic IEC or human colonoid-derived IEC treated with CD47-blocking antibodies demonstrate impaired epithelial cell migration in wound healing assays. Defective wound repair after CD47 loss is linked to decreased epithelial β1 integrin and focal adhesion signaling, as well as reduced thrombospondin-1 and TGF-β1. These results demonstrate a critical role for IEC-expressed CD47 in regulating mucosal repair and raise important considerations for possible alterations in wound healing secondary to therapeutic targeting of CD47.
C D47 is a ubiquitously expressed cell surface glycoprotein that associates with a variety of receptors to facilitate critical cell signaling events. Of considerable interest, CD47 has been implicated to regulate innate immune cell tolerance of self through its ability to ligate signal-regulatory protein alpha/SIRPα on myeloid immune cells and inhibit phagocytosis of circulating CD47-expressing erythrocytes 1-6 . This mechanism is currently being exploited in studies on CD47 as a potential target for immunotherapeutics intending to augment immunemediated destruction of cancer cells that overexpress CD47 7, 8 .The altered susceptibility of Cd47-deficient mice to inflammatory insults further suggest that CD47 expression is an important modulator of leukocyte function during pro-inflammatory immune responses [9] [10] [11] [12] [13] [14] . However, a lack of tissue-targeted knockout mice has limited studies that address the function of CD47 expression by non-hematopoietic cell types in vivo.
It is well appreciated that adhesion and collective migration of epithelial cells is particularly important during mucosal wound closure, as restoration of the epithelial barrier is necessary for the resolution of inflammation 15 . Studies suggest that collective migration of epithelial cell monolayers across denuded surfaces requires dynamic regulation of β1 integrin signaling, which directs the rapid formation and dissolution of focal adhesions [16] [17] [18] . In vitro studies using cell lines suggest that CD47 is also an important regulator of integrin signaling through in cis interactions with integrin heterodimers. Specifically, it has been reported that CD47 expression regulates integrin-dependent cell adhesion and migration in smooth muscle cells, platelets, and epithelial cells in vitro [19] [20] [21] [22] , as well as enabling integrin-mediated leukocyte adhesion and extravasation in vivo 23 . However, the potential regulation of epithelial β1 integrin signaling by CD47 during mucosal wound closure in vivo has not been investigated. Noteworthy, CD47 has been reported to play a role in tissue repair with improved healing and survival in several in vivo models including skin thermal injury and ischemia/reperfusion in organ transplant models of liver, kidney, and skin [24] [25] [26] [27] [28] [29] . Given these observations, we surmised that expression of CD47 in epithelial cells may play an important role in regulating mucosal wound closure in vivo. Studies were performed to evaluate the role of epithelial CD47 expression in models of intestinal mucosal injury and repair in vivo. Here, we report that Cd47-deficient mice and wild-type animals infused with CD47-neutralizing antibodies have markedly impaired biopsy-induced colonic wound closure. We further demonstrate a critical role of epithelial expressed CD47, as mice selectively deficient in intestinal epithelial cell (IEC) CD47 expression did not display abnormalities under resting conditions but exhibited profound defects in closure of biopsy-induced mucosal wounds as well as markedly impaired colonic mucosal wound repair from cyclic exposure to dextran sodium sulfate (DSS)-induced injury. Using two-dimensional (2D) cultures of primary epithelial cells derived from murine and human intestine, it was determined that CD47 regulates epithelial cell migration and wound closure through β1 integrin-dependent signaling through Focal adhesion kinase (FAK), Src protein-tyrosine kinase, and Crk-associated substrate p130Cas (p130Cas), thereby controlling the formation of focal cell matrix adhesions. In addition, we observed that loss of CD47 negatively regulates the level of expression of its ligand thrombospondin-1 (TSP-1) and effector cytokine Transforming growth factor beta (TGF-β1) both known to facilitate wound healing [30] [31] [32] , resulting in alteration of downstream signaling pathways. Herein, we corroborate evidence of crosstalk between CD47, β1 integrin, and focal adhesions as well as a functional link between CD47, TSP-1, and TGF-β1 in the intestinal epithelium. These findings provide insights into a central role of CD47 in regulating IEC migration and mucosal wound repair in vivo, and raise the possibility of altered wound healing as a potential complication in clinical studies exploring blockade of CD47 to enhance clearance of CD47-overexpressing tumor cells in humans.
Results
CD47 expression is required for mucosal repair in vivo. Previous studies with total Cd47 knockout mice (Cd47 −/− ) have shown varied results in response to inflammatory challenge, including a protective effect of CD47 deficiency during ischemia/ reperfusion injury and total body irradiation 13, 28 , as well as in response to certain pathogens 33 . However, CD47 deficiency has also been reported to increase susceptibility to systemic Escherichia coli and Candida albicans infection 10, 11 . As mucosal wound repair in the intestine requires coordinated epithelial migration and proliferation in concert with temporal immune responses 15 , we hypothesized that CD47 may have an important role in regulation of wound healing. To test this hypothesis, we utilized a mucosal repair model employing miniaturized endoscopic biopsy-based mechanical injury and video analysis of recovery in the colonic mucosa of Cd47 −/− mice. To analyze repair, sizes of mucosal wounds were digitally quantified 1 day after initial wounding and compared with sizes of the same wounds 2 days later. Cd47 −/− mice showed markedly inhibited wound closure compared with wild-type controls ( Fig. 1a ).
Although the above results suggest that loss of CD47 impairs mucosal wound closure, recent studies employing systemic blockade of CD47 with monoclonal antibodies suggest beneficial effects in some murine models of inflammation 34, 35 . We therefore tested whether systemic or local administration of CD47-blocking antibodies had inhibitory effects on mucosal wound healing. Indeed, intraperitoneal injection of the CD47-blocking antibodies miap301 or miap410 significantly inhibited wound closure in C57Bl/6 mice ( Fig. 1c ). As systemic blockade of CD47 would be expected to alter immune cell extravasation 23 , we locally injected CD47-blocking antibodies directly into colonic wound beds 24 h post wounding and assessed wound closure. Similar results to those observed with systemic antibody administration as well as in Cd47 knockout mice were obtained ( Fig. 1b, c ), suggesting that both localized and systemic neutralization of CD47 significantly delay mucosal wound healing.
Loss of epithelial CD47 impairs wound healing responses. As CD47 is ubiquitously expressed, understanding contributions of specific CD47-expressing cell types in mucosal wound-healing responses is critical to gain detailed mechanistic insights. Unfortunately, in vivo studies on CD47 function have been hindered by a lack of tissue-targeted, selectively deficient Cd47 knockout mice. Given that mucosal wound healing is dependent on coordinated migration and proliferation of the intestinal epithelium, and CD47 is implicated in cell adhesion and migration in vitro 19 , we created mice with selective loss of CD47 in the intestinal epithelium by generating Cd47 floxed mice (Cd47 f/f ), which were bred to mice constitutively expressing Cre under control of the Villin promoter (Cd47 ΔIEC ). Specific CD47 loss in IECs of Cd47 ΔIEC mice was confirmed by immunofluorescence labeling and western blotting ( Fig. 2a, b ).
As CD47 expression is described as an innate marker of self 4 , we anticipated that spontaneous immune-mediated destruction of the intestinal epithelium might develop in Cre-expressing mice. Cd47 ΔIEC mice weighed the same as littermate controls ( Supplementary Fig. 1a ) and exhibited no signs of spontaneous intestinal inflammation or epithelial barrier dysfunction. Furthermore, Cd47 ΔIEC mice did not show evidence of increased intestinal permeability to 4kD dextran ( Supplementary Fig. 1b ) consistent with normal barrier function. Histological examination of intestinal mucosa revealed normal architecture in Cd47 ΔIEC mice (Fig. 2d ), and no significant inflammation or alterations in major tissue-resident immune cell populations assessed by flow cytometry ( Fig. 2e ). To verify that the lack of observed spontaneous inflammation in Cd47 ΔIEC mice is not owing to immune compensation during development 5 , Cd47 f/f mice were also bred to animals expressing an ERT2-Cre fusion protein under control of the Villin promoter 36 to obtain mice with inducible loss of CD47 in the intestinal epithelium (Cd47 ERΔIEC ). Tamoxifen treatment of Cd47 ERΔIEC mice resulted in acute deletion of CD47 in IECs, which persisted 60 days post tamoxifen treatment ( Fig. 2a, c ). In agreement with results obtained from naive Cd47 ΔIEC mice, Cd47 ERΔIEC mice showed no signs of altered intestinal epithelial barrier function or pathologic mucosal inflammation, as evidenced by analysis of body weight, mucosal histology/immune cell populations, and barrier function (Supplementary Fig. 1c-e ).
Having established that IEC-targeted Cd47-deficient mice do not develop significant intestinal pathology under baseline conditions, we tested whether epithelial CD47 expression is required for mucosal wound healing. Consistent with our findings in Cd47 −/− mice and wild-type mice treated with anti-CD47 antibodies, Cd47 ΔIEC mice as well as tamoxifen-treated Cd47 ERΔIEC mice showed profound impairment in biopsy-induced wound closure between 1 and 3 days post wounding in comparison with littermate controls (Fig. 3a) . Thin cross-sections of wound beds labeled with the epithelial-specific marker E-Cadherin and brush border protein Villin revealed the absence of polarized woundassociated epithelial cells expressing Villin in Cd47 ΔIEC mice compared with control Cd47 f/f mice (Fig. 3b, c ). In addition, examination of proliferation of cells in crypts adjacent to mucosal wounds isolated from Cd47 ΔIEC and tamoxifen-treated Cd47 ERΔIEC mice revealed similar numbers of Ki67-labeled epithelial cells ( Fig. 3d ), indicating similar levels of epithelial cell proliferation regardless of CD47 expression. Collectively, these findings indicate that epithelial CD47 promotes colonic mucosal wound healing by regulating IEC migration but not cell proliferation.
In order to verify the observed, wound healing defects in Cd47 ΔIEC and tamoxifen-treated Cd47 ERΔIEC mice, we utilized a second model of chronic colonic mucosal injury and repair that employs cyclical administration of DSS in drinking water followed by recovery with water alone. When subjected to alternating cycles of DSS administration and water-only recovery, both Cd47 ΔIEC and tamoxifen-treated Cd47 ERΔIEC mice developed escalating clinical colitis scores (Disease Activity Index (DAI)) as determined by weight loss, stool consistency, and presence of blood in stools, in comparison with littermate controls (Fig. 4a, b ). Colitis/DAI was more pronounced following induced deletion of CD47 in tamoxifen-treated Cd47 ERΔIEC mice (Fig. 4b ). Histological analysis of the colonic mucosa after three cycles of DSS and water administration revealed significantly worse mucosal injury and less repair in Cd47 ΔIEC mice and tamoxifen-treated Cd47 ERΔIEC mice, with increased crypt loss and mucosal ulceration evident in the distal colon ( Fig. 4c-e ). PMN/ granulocytes were visualized in the inflamed colonic mucosa of both genotypes with prominent accumulations of PMN observed in Cd47 ΔIEC mice ( Supplementary Fig. 2 ). These findings indicate that loss of CD47 results in impaired mucosal recovery associated with persistent inflammation in Cd47 ΔIEC mice in response to chronic DSS. In contrast, acute DSS treatment without recovery period did not produce statistically significant disease differences between groups ( Supplementary Fig. 3a, b ), further supporting impaired mucosal healing responses in Cd47 ΔIEC and Cd47 ERΔIEC mice.
CD47 regulates focal adhesion-dependent IEC migration. To gain further insight into the molecular basis of delayed wound closure in epithelial cells lacking CD47, we analyzed wound closure in cultures of primary epithelial cells derived from either murine small intestinal enteroids or from human stem cellderived epithelial colonoids. Murine CD47-deficient enteroid Fig. 4a, b ). Subsequently, 2D epithelial cell monolayers were generated from CD47( + ) or CD47(−) enteroids and subjected to scratch-wound healing assays. Although epithelial proliferation rates were similar between CD47( + ) and CD47(−) cultures ( Supplementary Fig. 4c ), time lapse imaging of scratch induced wounds revealed significantly delayed closure in monolayers lacking CD47 ( Fig. 5a ).
To further verify that blockade of CD47 impairs closure of wounds, we incubated human colonoid-derived epithelial monolayers with the well-characterized CD47-blocking antibody B6H12 37 . In comparison with IgG control, treatment with B6H12 significantly reduced wound closure, whereas incubation with the non-blocking anti-CD47 antibody 2D3 did not impede wound closure (Fig. 5b) . Similar results were obtained by treating Cd47 CD47-expressing murine epithelial monolayers with the blocking anti-CD47 antibodies miap301 or miap410 ( Supplementary  Fig. 5 ), further supporting a functional requirement for CD47 in epithelial scratch-wound closure. Collectively, these in vitro results support the above in vivo findings ( Fig. 3) suggesting that IEC-expressed CD47 does not regulate cell proliferation but acts to promote epithelial cell migration in response to wound injury. Previous in vitro studies have suggested that CD47 has a role in regulation of integrin-dependent leukocyte adhesion through direct interaction with αVβ3 integrin in neutrophils and α4β1/ αLβ2 integrins in T cells 23, 38 . In epithelial cells, it is wellestablished that integrin alpha-beta heterodimers containing the β1 subunit play a major role in epithelial cell migration through formation of focal adhesion complexes 17, 18 , yet an interaction between CD47 and β1 integrins has not been investigated in the intestinal epithelium. We utilized an in situ proximity ligation assay (PLA) to test whether CD47 closely interacts with β1 integrin in murine colon. In Fig. 6a positive PLA signals were observed as green spots in IEC and immune cells with far fewer PLA signals observed in colonic crypts from Cd47 ΔIEC mice (Fig. 6a ). Importantly, in Supplementary Fig. 6 , we demonstrated specificity of PLA staining in using Cd47 −/− and Cd47 +/+ mice. As expected, no PLA signals were detected on IEC or immune cells in the colonic mucosa from Cd47 −/− mice.
Previous studies have revealed that cell migration is dependent on temporal β1 integrin-dependent focal adhesion complex formation in epithelial cells with recruitment and autophosophorylation of FAK at nascent adhesions, followed by the Src kinase-dependent phosphorylation of the adaptor protein p130Cas [39] [40] [41] . We assessed whether this signaling pathway is altered in the absence of epithelial CD47 expression. Indeed, freshly isolated IECs from Cd47 ΔIEC mice revealed reduced β1 integrin protein expression in comparison with Cd47 f/f controls, reduced Src phosphorylation at residue Y416 and FAK tyrosine phosphorylation at residues Y397 and Y861 (pFAK Y397 , pFAK Y861 ) as well as phosphorylation of p130Cas Y410 without change in total levels of Src and FAK (Fig. 6b ). Similar results were obtained in wounded 2D epithelial cultures derived from murine enteroids, where CD47(−) monolayers had reduced β1 integrin protein, p-Src Y416 , pFAK Y397 , pFAK Y861 , and p130Cas Y410 after wounding ( Fig. 6c ). Reduction of β1 integrin protein expression and altered pFAK Y861 in the absence of epithelial CD47 in vivo was a b c
Colonic mucosal injury confirmed through immunofluorescence staining and imaging of epithelium adjacent to healing wounds. Epithelial cells from Cd47 ΔIEC mice showed reduced basal staining for β1 integrin and pFAK Y861 and reduced colocalization of remaining β1 integrin and pFAK Y861 at the base of the epithelium (Fig. 6d ).
As β1 integrin-dependent signaling through FAK and p130Cas is necessary to direct formation and stabilization of adhesions in lamellipodia of migrating epithelial cells 16, 40 , we analyzed focal adhesions in CD47(−) murine enteroid-derived epithelial cells. Immunofluorescence labeling of epithelial cells at the edges of healing wounds revealed typical focal adhesions in lamellipodia of leading-edge cells, visible as linear parallel pFAK Y861 -staining structures connecting to the actin cytoskeleton in CD47( + ) cells. In contrast, very few pFAK Y861 -staining focal adhesions were evident in lamellipodia of migrating CD47(−) (Fig. 6e) . Similar results were obtained with pFAK Y397 -staining lamellipodia of migrating CD47(−) cells that was irregular and punctate in comparison with CD47( + ) cells ( Supplementary  Fig. 7 ). In combination with observations of altered signaling downstream of β1 integrin in CD47-deficient cells, these results are consistent with a model of CD47-dependent regulation of β1 integrin function and integrin-dependent regulation of focal cell matrix adhesion proteins, which control epithelial cell motility and thus contribute to wound closure.
CD47 regulates levels of TSP-1 and active TGF-β. The CD47 soluble protein ligand TSP-1 has been reported to facilitate tissue repair, as Tsp1-null animals has been shown to have delayed dermal wound healing and enhanced susceptibility to DSScolitis 30, 42 . We thus investigated whether loss of CD47 had an impact on TSP-1 expression in IEC. As shown in Fig. 7a , reduced expression of TSP-1 was detected in IEC freshly isolated from Cd47 ΔIEC mice in comparison with IEC from Cd47 f/f mice at baseline. As TSP-1 has been reported to be an activator of latent TGF-β1 to facilitate wound healing, re-epithelization and collagen synthesis 32, 43 , we examined the effect of CD47 loss on activation of TGF-β1 and its downstream effectors as well as collagen deposition in colonic mucosa after injury. Freshly isolated IEC that lack CD47 expression had decreased expression of the mature cleaved form of TGF-β1 and accumulation of the immature propeptide ( Fig. 7a ). Total expression levels and phosphorylation of Smad2 and Smad3 were reduced similarly in IEC from Cd47 ΔIEC mice in comparison with Cd47 f/f controls (Fig. 7a ). Consistent with these findings, we observed less collagen staining in Cd47 ΔIEC mice compared with Cd47 f/f controls after chronic DSS-induced colitis or biopsy-based wounds at day 3 (Fig. 7b ). Collectively, these data strongly suggest that in addition to controlling focal adhesion activity, CD47 also promotes intestinal wound healing through effects on epithelial levels of TSP-1 and TGF-β1. Despite the ubiquitous expression of CD47, very little is known about its function in non-hematopoietic cells. Previous studies employing models of inflammation in Cd47-null mice (Cd47 −/− ) [9] [10] [11] 13, 14 or mice treated with CD47-neutralizing antibodies 34, 35 support both protective and pathological roles for CD47 expression, yet are highly model-dependent and limited in their ability to distinguish between the relative contributions of CD47-deficient cell types in vivo. Here, we provide in vivo mechanistic insights into the functions of CD47 on IEC during homeostasis and in response to chemically or mechanically induced wounds. We have established that CD47 expression is required for normal mucosal wound healing, as Cd47 −/− mice exhibited impaired colonic wound repair, an effect that was recapitulated in wild-type mice treated with CD47-neutralizing antibodies. It is possible that the observed wound healing defect in mice treated with anti-CD47 antibodies may, in part, be secondary to altered leukocyte responses, as CD47 has been reported to modulate leukocyte trans-endothelial migration 23, 34 , cytokine production [44] [45] [46] , and bacterial killing 10 . Indeed, future studies utilizing cell type specific deletion of CD47 will be required to explore in depth the function of CD47 expression in other cell types during mucosal wound healing. However, here we show that epithelial CD47 expression is specifically required for mucosal wound healing, as Cd47 ΔIEC and tamoxifen-treated Cd47 ERΔIEC mice exhibited profound impairment of mucosal biopsy wound closure and develop escalating mucosal damage after cyclical DSS treatment and recovery. Similar to a previous report that used Cd47-null mice 47 , we observed no direct consequences of loss of CD47 on IEC in response to acute DSS treatment in Cd47 ΔIEC or Cd47 ERΔIEC mice in comparison with controls. The same study also reported that Cd47-null mice are protected against prolonged administration of DSS to model chronic colitis owing to attenuated granulopoiesis leading to reduced PMN accumulation in colonic mucosa. Herein, our findings indicate that loss of CD47 on IEC rendered mice more susceptible to DSS-induced chronic colitis. Although we used a different DSS protocol for chronic colitis that mimics relapsing-remitting course of inflammatory bowel disease 48,49 , a major difference with the previous study by Bian et al. 47 is that we used animals with selective deletion of CD47 on IEC rather than total body knockouts. Given that all other tissues including immune cells express CD47, one would not expect to observe alterations in granulopoeisis as well as primary defects in the capacity of granulocytes to be recruited into the intestinal mucosa after biopsy or DSS treatment. Indeed, PMN/granulocytes were detected in the inflamed mucosa of all genotypes Cd47 ΔIEC , Cd47 ERΔIEC , and control Cd47 f/f mice after the last cycle of chronic DSS-induced colitis. We observed prominent infiltrates of PMN/granulocytes and large areas of crypt ulceration in Cd47 ΔIEC and Cd47 ERΔIEC mice, consistent with extensive epithelial damage and persistent inflammatory responses.
Studies employing transfer of CD47-deficient hematopoietic cells into wild-type hosts have informed the hypothesis that CD47 expression serves as an important marker of self, protecting CD47-expressing cells against errant destruction by phagocytic immune cells [3] [4] [5] . It was therefore unexpected to find a lack of immune-mediated mucosal damage upon acute deletion of intestinal epithelial CD47, yet this observation is consistent with initial studies reporting that Cd47 −/− mice are more or less healthy in pathogen-free conditions 10 . Although the reason for healthy Cd47 ΔIEC mice is not clear, certain macrophage functions could be dependent on licensing through exposure to CD47expressing cells during development in order to sense CD47deficient cells as non-self 5 . We found that both Cd47 ΔIEC and tamoxifen-treated Cd47 ERΔIEC mice did not experience spontaneous immune-mediated destruction of the intestinal epithelium. Cd47 ERΔIEC mice were more sensitive to DSS-induced colitis than ΔIEC mice, suggesting the possibility of a minor degree of innate immune compensation may occur during development. However, our observation that acute deletion of CD47 in the intestinal epithelium of adult Cd47 ERΔIEC mice is not sufficient to perturb intestinal homeostasis argues against this concept, as tissueresident macrophages in these mice are continuously exposed to CD47-expressing epithelial cells prior to tamoxifen administration. Overall, our findings support a growing body of evidence suggesting that phagocytic activity directed at CD47-deficient cells likely involves other pro-phagocytic signals, or may be restricted to specific populations of macrophages and dendritic cells in vivo.
The process of mucosal barrier restitution upon wounding is dependent on coordinated migration of wound-adjacent epithelial cells 15 , whereas epithelial cell adhesion and migration is known to be dependent on the dynamic regulation of β1 integrincontaining focal adhesions 17, 18 . Experiments conducted in vitro with 2D cultures of primary epithelial cells derived from murine enteroids or human colonoids confirmed that the absence or blockade of CD47 is sufficient to impair migratory capacity of ARTICLE wounded epithelial monolayers. The current studies provide mechanistic evidence that epithelial CD47 expression regulates mucosal wound closure in vivo by promoting signaling through a β1 integrin-dependent FAK-Src-p130Cas pathway 39, 41, 50 , thereby enabling focal adhesion complex formation and epithelial cell migration across wounded surfaces. Given that CD47 is expressed ubiquitously, these data suggest that CD47 may function as a fundamental regulator of integrin-dependent cellular processes in many tissues. In support of this, cellular processes as distinct as neuronal development 51 , smooth muscle cell chemotaxis 21 , and leukocyte adhesion and phagocytosis 23, 37, 38, 52 are reported to require both CD47 expression and the dynamic regulation of integrins. The exact nature of the interaction between CD47, β1 integrins and focal adhesions remains to be elucidated. In situ proximity ligation assays (PLA) confirmed close interaction between CD47 and integrin β1, as positive PLA signals were detected both in IEC and immune cells. These findings are consistent with other studies reporting direct interactions between CD47 and β1 integrins, α2β1 and α4β1 53, 54 .
We detected reduced expression of β1 integrin protein and reduced/altered focal adhesions in CD47-deficient epithelial cells, suggesting that CD47 may facilitate cell migration by stabilizing β1 integrin protein expression. This would, in turn, promote the formation of, or prevent the dissolution of, β1 integrin-containing focal adhesion complexes 40, 55, 56 . Furthermore, we observed that in the absence of CD47 on IEC, phosphorylation of Src Y416 was reduced under basal conditions in freshly isolated IEC from Cd47 ΔIEC mice as well as in 2D primary IEC cultures in response to wound scratch injury. Our results in IEC corroborate previous studies in CD47-deficient neurons, demonstrating that autophosphorylation of Src was reduced, whereas overexpression of CD47 resulted in Src autophosphorylation 51 . Noteworthy, inhibition of Src has been reported to prevent CD47-promoted neuronal dendrite development as well as CD47-induced epithelial cell spreading, supporting a role for CD47 in epithelial cell migration and dendrite development via regulation of Src activity 51, 57 .
The mechanism by which CD47 activates Src kinase is currently unknown. Given our findings of reduced phosphorylation of FAK in the absence of CD47 on IEC and reports of FAK acting as a molecular scaffold protein that recruits and activates Src, we speculate that FAK may play a key role in the regulation of Src by CD47. Of note, it has also been reported that Src-induced tyrosine phosphorylation of FAK is required for focal adhesion activity 50, 58 . Collectively, these observations provide evidence for involvement of a functional axis consisting of CD47-FAK-Src in regulating CD47-dependent IEC migration. Interestingly, we found that the widely used anti-CD47 antibody B6H12, that inhibits binding of both ligands SIRP-α and TSP-1 to CD47, also resulted in reduced wound healing when applied to human stem cell-derived colonoids in vitro. Given that these human colonoids do not express SIRP-α ( Supplementary Fig. 8 ), our results suggest that the effect of B6H12 mAb on epithelial wound healing may be owing in a large part to inhibition of the interactions between CD47 and TSP-1. However, we cannot exclude the possibility that binding of B6H12 mAb on CD47 may trigger intracellular signaling, as has been described in other types of cells (Supplementary Fig. 9 ) 59, 60 .
Previous studies have reported that Tsp1-deficient mice displayed delayed wound healing and increased susceptibility to colitis 30, 61 . Furthermore, TSP-1 is a major physiologic activator of latent TGF-β1, and TGF-β1 is described to be important for collagen deposition facilitating wound healing 29, 32 . Here, we found that loss of CD47 on IEC resulted in reduced expression of TSP-1, cleaved/ active form of TGF-β1 as well as reduced phosphorylation of TGF-β1 downstream effectors, Smad2, and Smad3 in freshly isolated IEC from Cd47 ΔIEC mice. We also observed less collagen staining in Cd47 ΔIEC mice compared with Cd47 f/f mice three days after biopsy and following chronic DSS. It is tempting to speculate that decreased levels of expression of TSP-1 might contribute to observed phenotype in CD47-deficient IEC. These findings appear to be at odds with a report of improved wound repair in a dermal injury model using Cd47-deficient mice showing increased expression of TSP-1, activation of TGF-β1, increased Smad2/3 phosphorylation and increased deposition of collagen 29 ; however, the latter used animals lacking CD47 in all cells of the body in contrast to our study that used mice with selective depletion of CD47 in IEC. Despite this difference, it is entirely possible that CD47 function in dermal epithelium is different than in IEC. Furthermore, both of these studies clearly support important contributions of CD47, TSP-1, and TGF-β1 in regulating epithelial repair after injury while highlighting the existence of tissue-specificity in the contributions of CD47 wound healing.
Although the precise mechanism by which CD47, TSP-1, and TGF-β1 cooperate to promote intestinal wound healing is unclear, it is possible that reduced levels of TSP-1 may lead to less activation of TGF-β1. This hypothesis is consistent with a previous report of Tsp1-deficient mice that exhibited aberrant skin wound healing, and topical application of a TSP-1-derived peptide (KRFK) was shown to enhance local expression of TGF-β1 in the wounds of Tsp1-deficient mice and rescued the wound healing process 32 . Moreover, TSP-1 and TGF-β1 have been reported to regulate FAK activity 62 and ligation of CD47 by TSP-1 or specific TSP-1 peptides has been shown to regulate αvβ3 integrin-mediated cell spreading 63 . It is likely that TSP-1 and TGF-β1 might also functionally link CD47 to FAK. Collectively, these findings suggest the existence of a complex molecular network that regulates the CD47-dependent activation of FAK as well as IEC migration. Indeed, other CD47-associated proteins may also contribute to the process such as ubiquitin-related protein, PLIC-1 which has been suggested to regulate the actin cytoskeleton and cell migration 64, 65 . The individual contributions of these signaling networks in regulating IEC migration after injury require further investigation.
Moreover, our observation that blockade of CD47 by antibody administration is sufficient to impair mucosal wound healing raises important considerations for therapeutic targeting of CD47. As immunotherapeutics directed against tumorexpressed CD47 are currently being tested in clinical trials, impaired wound healing may be an unintended consequence in cancer patients undergoing surgical resection, particularly in the gastrointestinal tract.
Materials and methods
Mice. Cd47 knockout mice on a C57Bl/6 background were purchased from Jackson Laboratories and bred in-house at the University of Michigan in Ann Arbor. Dextran sulfate sodium treatment. Mice were provided with 2.5% w/v DSS (40-kDa, 14489, Affymetrix) in drinking water ad libitum for indicated times followed by 5 days with normal drinking water 48, 49 . Clinical disease assessment was obtained daily, with scores of 0-4 assigned for weight loss, stool consistency, and presence of blood in stools. The individual scores were added and the average recorded as the disease activity index (DAI). Higher values of DAI reflect increasing severity of colitis. At the end of the experiment, mice were sacrificed and colons harvested. Hematoxylin-Eosin (H&E) staining of sections of Swiss roll mounts of the entire colon (8-μm thick) was performed to quantify colonic mucosal injury. Percentage of injury/ulceration was calculated as a ratio of the length of injured/ulcerated area (≥ 50% crypt loss) relative to the entire colon length.
Intestinal enteroid and monolayer culture. Murine small intestinal epithelial enteroids/colonoids were created and maintained in culture. Mouse intestine was dissected and flushed with phosphate-buffered saline (PBS) and transferred to chelation buffer (2 mM EDTA, PBS) for 30 min. The intestine was shaken to remove crypt cells and then incubated in PBS with 43 mM sucrose and 55 mM sorbitol and filtered through a 70-μm filter 67 . Isolated intestinal crypts from untreated Cd47 ERΔIEC mice were embedded in Matrigel (BD Biosciences) (30 µl/well) and maintained in LWRN conditioned complete media supplemented with 50 ng/ml recombinant human EGF (R&D Systems) and 100× antibiotics-antimycotic (Corning). In some experiments, enteroid cultures derived from Cd47 ERΔIEC mice, were treated for 72 h with 1 μM z-4-hydroxytamoxifen (#H7904, Sigma Aldrich) in complete media to acutely knockdowm CD47 followed by passage and maintenance in tamoxifen-free complete media.
LGR5+ stem cell-derived human colonoids were provided by Jason Spence (University of Michigan) and maintained in Matrigel (BD Biosciences) in GMGF media composed of Advanced DMEM/F12, 10% FBS, 2 mM GlutaMAX-1, 10 mM HEPES, and 100 U/ml Penicillin/streptomycin (all from Invitrogen) 68 .
To generate 2D epithelial intestinal monolayers from murine or human 3D enteroids/colonoids, a single-cell suspension was obtained by resuspension in 0.05% Trypsin/0.5 mM EDTA and vigorously pipetting up and down. Trypsin was inactivated by adding 1 ml advanced DMEM/F12-containing 10% FBS. Dissociated cells were passed through a 40 µm cell strainer, then cultured in collagen type IV-coated 48-well tissue culture plates until confluency was achieved (~48 h). Murine 2D cultures were maintained in LWRN complete media supplemented with 50 ng/ml recombinant human EGF and antibiotics/ antimycotic. Human 2D cultures were maintained in differentiation media containing GMGF media supplemented with 10 nM Gastrin and 1 mM N-Acetylcysteine (Sigma), 10 mM Nicotinamide, 10 µM SB202190 (StemCell Tech), 500 nM A83-01 (StemCell Tech), 10 ng/ml EGF (R&D systems) 68 .
Wound healing assays. For in vitro experiments, 2D cultures of murine or human epithelial enteroids/colonoids were subjected to scratch wounding assays. Monolayers were cultured on collagen type IV (#C5533, Sigma)-coated 48-well tissue culture plates to confluency and scratched using a 10 μl pipette tip under suction. Medium was changed after wounding and video quantification of scratch-wound closure was performed by imaging wounds at 10 min intervals in an Axiovert Observer live cell microscopy system (Zeiss). Wound closure was quantified at the indicated time points using ImageJ software (National Institutes of Health), calculated as percent reduction of cell-free surface area compared with immediately after wounding (t = 0) 66 . For antibody-mediated neutralization experiments, antibodies were added immediately after wounding (time 0). Human primary epithelial monolayers were treated for 24 h with 10 μg/ml of IgG control (14-4714-82; Thermofisher), function-blocking anti-CD47 antibody (clone B6H12.2) or nonblocking anti-CD47 antibody (clone 2D3). Mouse primary epithelial monolayers were treated for 24 h with 10 μg/ml of rat IgG2A (clone 2A3), miap301 or miap410. For Western Blot analysis, multiple scratches were created to enrich the migratory fraction of cells before being collected in lysis buffer at indicated times.
For in vivo wounding experiments, a biopsy-based mucosal wound model was employed employed using a high-resolution video endoscope (Coloview Veterinary Endoscope, Karl Storz) equipped with biopsy forceps to create biopsy-induced injury of the colonic mucosa at five to seven sites along the dorsal aspect of the colon of anesthetized mice (i.p. injection of ketamine 100 mg/kg, xylazine 5 mg/kg). Wound healing was quantified at 24 h and 72 h after injury. Endoscopic procedures were viewed with high-resolution (1024 × 768 pixels) images on a flat-panel color monitor. Each wound region was digitally photographed at 24 h and 72 h, and wound areas calculated using ImageJ (National Institute of Health, USA). In each experiment, three to five wounds per mouse were quantified 66 . For antibodymediated neutralization experiments, rat IgG2A (clone 2A3), miap301 or miap410 antibodies were intraperitoneally-administrated (400 µg in sterile PBS) or were injected directly into wound beds via veterinary endoscope 24 h post-wounding (10 µg in sterile PBS).
For immunofluorescence analysis, wounds were harvested from colons by punch biopsy, embedded and flash-frozen in OCT embedding compound, followed by sectioning (6 μm thick) and staining as indicated.
Immunofluorescence. Frozen tissue sections (6μm thick) were fixed at room temperature in 4% paraformaldehyde, followed by blocking and permeabilization with 3% bovine serum albumin/0.5% Triton X-100 in PBS. Primary antibodies were incubated overnight at 4°C in blocking buffer, followed by fluorescent secondary antibodies at room temperature for 1 h. Alexa Fluor 555 Phalloidin (A34055, Invitrogen) was used to stain F-actin and DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride) (D1306, Invitrogen) for nuclei. Slides were washed and mounted with Pro-Long Antifade Reagent (Thermo Fisher) prior to analysis as indicated.
In situ proximity ligation assay (PLA) was used to identify interactions between CD47 and integrin β1. Positive PLA signals, detected as a fluorescent dot by immunofluorescence microscopy, are produced when two labeled proteins are closely apposed within 40 nm. In situ PLA was performed on frozen tissue sections, fixed at room temperature in 4% paraformaldehyde, followed by blocking and permeabilization with 3% bovine serum albumin/0.5% Triton X-100 in PBS. DuoLink PLA probes and reagents (Sigma Aldrich) were used following the manufacturer's instructions. Anti-Goat plus/DUO92003 was used to label anti-CD47 antibody and probemaker minus/DUO92010 for anti-integrin β1 antibody. Tissues were then stained with anti-beta-catenin antibody and DAPI. Positive and negative control experiments were performed using colonic mucosa from Cd47 +/+ and Cd47 −/− mice, respectively.
Western blot. Cells were lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, 50 mM Tris pH 8.0), followed by sonication and centrifugation. Protein concentrations were quantified using BioRad DC Protein Assay (BioRad). Equal quantities of protein samples were loaded into 8% polyacrylamide gels for SDS-PAGE and transferred to polyvinylidene fluoride membrane. Membranes were blocked with either 5% dry milk/TBS/Tween-20 or 3% BSA/TBS/Tween-20 for phosphorylated proteins, followed by overnight incubation with primary antibodies at 4°C. Membranes were then incubated with appropriate HRP-conjugated secondary antibodies for 1 h at room temperature, followed by development using Clarity Western ECL Substrate and image capture by Chemi-Doc imager (BioRad). Uncropped and unprocessed scans of western blots are provided in the source data file.
Flow cytometry. Lamina propria digests were prepared from whole colonic tissue by washing with chelation buffer to remove epithelial cells (10 mM EDTA in PBS), followed by digestion in RPMI media with 200 μg/ml Liberase TM (Roche Applied Science, Indianapolis, IN) and 200 U/ml DNase I (Sigma Aldrich). Cells were suspended in flow buffer (2% FBS/1 mm EDTA in DPBS) and incubated with the following fluorescent conjugated anti-mouse antibodies for 30 min at 4°C: CD45, F4/80, CD11b, CD11c, Ly6G, Ly6C, Siglec F, CD19, CD3ε, CD4, and CD8α.
For detection of SIRPα, human epithelial colonoids were harvested by trypsinization, and washed twice in PBS. As positive controls, human peripheral NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12968-y ARTICLE blood polymorphonuclear leukocytes were isolated from whole blood obtained from healthy human volunteers, with approval from University of Michigan institutional review boards on human subjects. Human peripheral venous blood was collected and neutrophils were isolated using density gradient centrifugation on Polymorphprep (Cosmo Bio Usa Inc AXS1114683) at 450 × g for 35 min at 20°C. Contaminating erythrocytes were removed by hypotonic lysis. Neutrophils isolated with this method were 97% pure and > 95% viable 69 . Cells were then suspended in 200 μl of PBS containing 2% FBS and incubated with 10 μg/ml of murine monoclonal antibodies against human SIRPαD1 (clones SAF10.1 and SAF17.2) or SIRPαD3 (SAF4.2) 70 or anti-human CD47 (clone B6H12) mAb for 45 min at 4°C. After incubation, cells were washed twice in PBS containing 2% FBS, and incubated for 30 min at 4°C with an Alexa Fluor 488-conjugated goatanti-mouse Ab.
To evaluate integrin β1 activation after antibody binding to CD47, human epithelial colonoids were harvested by trypsinization, and washed twice in HEPES/ NaCl buffer (20 mm HEPES, 150 mM NaCl, 2 mg/ml D-glucose, pH 7.4). β1 integrin activation was detected by using anti-β1 integrin epitope antibody HUTS-21 previously labeled with Zenon-Alexa Fluor 488 Mouse IgG2a Labeling Kit (Cat# Z25102, Invitrogen), following manufacturer instructions. Cells were incubated either with 20 μg/ml of B6H12 mAb or after addition of 1 mM Mn 2+ , as a positive to induce integrin activation, in presence of anti-β1 integrin epitope Ab HUTS-21 to detect activation of β1 integrin. After 30 min (37°C), cells were fixed in 4% paraformaldehyde for 10 min at room temperature followed by analysis on a NovoCyte flow cytometer (ACEA Biosystems, San Diego, CA). Data files were analyzed using FlowJo software (Tree Star, Ashland, OR).
Statistics. Statistical significance was measured by Student's t test, one-way or twoway ANOVA using Graphpad Prism software. Significance was set as p ≤ 0.05. Results are expressed as means ± standard error of mean.
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
